Your browser doesn't support javascript.
loading
A positive feedback loop between Periostin and TGFß1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen, Gang; Wang, Yi; Zhao, Xin; Xie, Xiao-Zai; Zhao, Jun-Gang; Deng, Tuo; Chen, Zi-Yan; Chen, Han-Bin; Tong, Yi-Fan; Yang, Zhen; Ding, Xi-Wei; Guo, Peng-Yi; Yu, Hai-Tao; Wu, Li-Jun; Zhang, Si-Na; Zhu, Qian-Dong; Li, Jun-Jian; Shan, Yun-Feng; Yu, Fu-Xiang; Yu, Zheng-Ping; Xia, Jing-Lin.
Afiliación
  • Chen G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China. chen.gang@wmu.edu.cn.
  • Wang Y; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China. chen.gang@wmu.edu.cn.
  • Zhao X; Liver Cancer Institute, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China. chen.gang@wmu.edu.cn.
  • Xie XZ; Division of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325005, China.
  • Zhao JG; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Deng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Chen ZY; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
  • Chen HB; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Tong YF; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
  • Yang Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Ding XW; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
  • Guo PY; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Yu HT; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
  • Wu LJ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Zhang SN; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
  • Zhu QD; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Li JJ; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
  • Shan YF; Department of Infectious Diseases, Shandong Provincial Hospital affiliated to Shandong University, Jinan, 250021, China.
  • Yu FX; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.
  • Yu ZP; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325005, China.
  • Xia JL; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325005, China.
J Exp Clin Cancer Res ; 40(1): 218, 2021 Jun 30.
Article en En | MEDLINE | ID: mdl-34193219
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Moléculas de Adhesión Celular / Carcinoma Hepatocelular / Factor de Transcripción AP-2 / Factor de Crecimiento Transformador beta1 / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Animals / Humans / Male / Middle aged Idioma: En Revista: J Exp Clin Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Moléculas de Adhesión Celular / Carcinoma Hepatocelular / Factor de Transcripción AP-2 / Factor de Crecimiento Transformador beta1 / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Animals / Humans / Male / Middle aged Idioma: En Revista: J Exp Clin Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China